U.S. health regulators authorized the use of Novavax Inc.'s COVID-19 vaccine, providing a new option that works differently than the two leading vaccines based on mRNA technology, but the move comes

FDA Authorizes New COVID Vaccine, From Novavax

06:50pm, Wednesday, 13'th Jul 2022
The move comes as the contagious BA.5 subvariant takes hold in the US.
Officials hope the protein-based vaccine will appeal to the nearly 22% of Americans who have not received a single dose of a Covid-19 inoculation.

FDA authorizes Novavax COVID vaccine for adults

05:17pm, Wednesday, 13'th Jul 2022
The FDA has given the green light to Novavax's COVID vaccine for adults, making it the fourth vaccine available for the coronavirus.

FDA Clears Novavax as a Covid-19 Vaccine

05:06pm, Wednesday, 13'th Jul 2022
The FDA says Novavax gives Americans “another option" to the three vaccines already authorized at a time when interest in vaccines is waning.
U.S. health regulators have authorized the use of Novavax Inc.'s COVID-19 vaccine, providing a new option that works differently than the two leading vaccines, but at a time when overall demand fo
FDA authorization of Novavax's vaccine was delayed for weeks as the agency reviewed changes to the company's manufacturing process.

Novavax (NVAX) Stock Pops Ahead of FDA Approval

10:20am, Wednesday, 13'th Jul 2022
NVAX stock has risen nearly 10% in the past five trading sessions on expectations that the FDA is going to approve its Covid-19 vaccine. The post Novavax (NVAX) Stock Pops Ahead of FDA Approval appear
NVAX stock looks due for a bounce-back as Novavax makes strides in providing Covid-19 vaccines in the U.S. and internationally. The post More Vaccine Jabs Means Novavax Stock Is Up for Grabs appeared
Regulatory clearance of the two-dose shot for adults could come as early as Wednesday, according to a Politico report.

Why Novavax Stock Shot Higher Today

05:20pm, Tuesday, 12'th Jul 2022
A media report says that the company's coronavirus vaccine is about to be authorized for use in the U.S.
Novavax (NVAX) inks a deal with the US government to supply 3.2 million doses of COVID shot. But the deal will be effective only if the vaccine gets EUA from the FDA.

Novavax Stock: Bear vs. Bull

06:00am, Tuesday, 12'th Jul 2022
Can this vaccine latecomer win market share?
The beaten-down vaccine stock's recent rebound could be just the beginning.
This article will compare Pfizer, Moderna, and Novavax to see which of these coronavirus stocks will yield the highest returns. The post Which Coronavirus Stock Could Fetch Higher Returns?
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE